I recently joined Radionetics Oncology, a San Diego-based venture-backed biotechnology company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications, as CEO. It’s a great team and Board, and I’m excited about the opportunity in front of us. I also joined the Board of Selecta Biosciences, a Boston-area public biotech, in the middle of last year as an independent Board member.
Contact Nishan at:
[email protected]